UPS (NYSE:UPS) announced today that its freight forwardingoperation at Changi Airport, Singapore, has received IATA CEIVPharma Certification for pharmaceutical logistics. Thecertification is the first for UPS in Asia Pacific and strengthensthe value proposition of UPS’s healthcare logistics offering in theregion. It is a further validation of its capabilities in the safe,secure and efficient transportation of high-value pharmaceuticalproducts.
IATA’s CEIV Pharma Certification is an industry certificationdeveloped by IATA, regulators and aviation industry stakeholders.It evaluates companies on a comprehensive range of criteriaincluding management systems, facilities, e,operations and staff expertise. The certification re to meet or exceed many existing pharmaceutical standardsand guidelines such as IATA Temperature Control Regulations,European Union Good Distribution Practices, World HealthOrganisation Annex 5 Good Distribution Practices for PharmaceuticalProducts and United States Pharmacopeia Standards.
“Pharmaceuticals are time and temperature-sensitive, re anextra amount of care throughout the transportation process. Theseare not typical packages, and at times life-saving deliveries aswell. This certification is an affirmation of the high standards ofhandling and transportation that UPS’s customers in the healthcareand life sciences sector have come to rely on for their high-valueshipments,” said Lim Bee Koong, Director, Healthcare Strategy, UPSAsia Pacific.
As a biomedical sciences hub for the Asia Pacific region, Singaporeis home to eight of the top 10 pharmaceutical companies globally,manufacturing four of the top 10 drugs by global revenue2. With athird of scrapped pharmaceuticals globally attributed to logisticsissues3, maintaining the integrity of the healthcare supply chainis crucial to Singapore’s biomedical manufacturing sector.
Enhancing its value proposition with an industry-leading set ofstandards like the IATA CEIV Pharma certification is part of UPS’svision to inspire trust and empower innovation to improve patientcare across the healthcare and life sciences ecosystem.